SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-005706
Filing Date
2023-12-05
Accepted
2023-12-05 18:42:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3370
  Complete submission text file 0001950047-23-005706.txt   4880
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Subject) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39311 | Film No.: 231468017
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BLVD., SUITE 260 NEWPORT BEACH CA 92660
Business Address
Akamine Scott (Reporting) CIK: 0001816720 (see all company filings)

Type: 144